Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on five products. UCERIS® (budesonide) extended release tablets for the induction ofremission in patients with active, mild to moderate ulcerative colitis and ZEGERID® (omeprazole/sodium bicarbonate) for the treatment of certain upper gastrointestinal disorders are promoted to gastroenterologists.

Biotechnology

Health Care

Life Sciences

Medical Devices

Santarus, Inc.

Santarus, Inc.'s headquarters in San Diego, CA, United States

Description

People (1)

Jobs (0)

Other offices